Clinical Trials Management and Advanced Operations

Dr. Ann-Margret Ervin is an Associate Scientist at Johns Hopkins University, with a focus on the design and conduct of randomized clinical trials, particularly in the field of ocular disease and visual impairment. Her research encompasses a wide range of topics, including age-related macular degeneration, cataracts, and diabetic retinopathy. Dr. Ervin serves as Co-Principal Investigator for several significant projects, including a multicenter observational study of Stargardt Disease and a clinical trial investigating the effects of lutein and zeaxanthin on ocular health. Additionally, she is engaged in research examining the ethical implications of federal regulations on institutional review boards (IRBs) and their impact on multicenter clinical trials.In her role at Johns Hopkins, Dr. Ervin also teaches courses on clinical trials management and quality assurance, contributing to the education of future public health professionals. Her extensive experience in clinical trial methodology and her commitment to improving research ethics make her a valuable asset to the field of epidemiology and public health.

Anne Shanklin Casper, MA, is a Senior Research Program Manager at Johns Hopkins University, specializing in clinical trials management and operations. With extensive experience in overseeing clinical research projects, she plays a crucial role in ensuring the successful execution of trials while adhering to regulatory standards and best practices. Her expertise encompasses various aspects of clinical trial management, including protocol development, participant recruitment, and data integrity. She is also an instructor for the course "Clinical Trials Management and Advanced Operations" on Coursera, where she shares her knowledge and skills with aspiring professionals in the field.In her role at Johns Hopkins, Casper collaborates with multidisciplinary teams to enhance the efficiency of clinical research processes. Her commitment to advancing clinical trial methodologies and her focus on training the next generation of researchers make her a valuable asset to the institution and the broader public health community.

Dr. Sheriza Baksh is an Assistant Scientist at Johns Hopkins University, specializing in the design and conduct of clinical trials and evidence synthesis. She earned her PhD from the Johns Hopkins Bloomberg School of Public Health, focusing on the cardiovascular safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus. Dr. Baksh is actively involved in research that examines pharmacoepidemiology and regulatory science, contributing to the development of analytic methods that enhance clinical trial methodologies. Her work is instrumental in advancing the understanding of safety signals in medications and improving clinical practices.In addition to her research, Dr. Baksh teaches "Clinical Trials Management and Advanced Operations" on Coursera, where she shares her expertise with students and professionals in the field. Her dedication to improving clinical research practices and her commitment to education make her a valuable asset to both Johns Hopkins University and the broader public health community.